返回 Agenda
Session Chair(s)
Session Chair Invited
United States
Speaker(s)
Discussant and Panelist: Nonclinical Track
Scott Henry, PHD
Ionis Pharmaceuticals, Inc., United States
Senior Vice President, Nonclinical Development
Discussant and Panelist: Nonclinical Track
Arthur A. Levin, PHD
Avidity Biosciences, United States
Distinguished Scientist
Discussant and Panelist: CMC Track
Daniel Capaldi, PHD
Ionis Pharmaceuticals, Inc, United States
Vice President, Analytical and Process Development
Discussant and Panelist: CMC Track
René Thürmer, PHD
Federal Institute for Drugs and Medical Devices, Germany
Quality Assessor
Discussant and Panelist: Clinical Track
James D. Thompson, PHD
Quark Pharmaceuticals Inc., United States
Vice President, Pharmaceutical Development
Discussant and Panelist: Clinical Track
Saraswathy V. Nochur, PHD, MSC
Alnylam Pharmaceuticals, United States
Chief Regulatory Officer